EPC
Edgewell Personal Care Company NYSE Listed Mar 27, 2000$21.64
Mkt Cap $1.0B
52w Low $15.88
44.2% of range
52w High $28.92
50d MA $21.56
200d MA $20.58
P/E (TTM)
42.6x
EV/EBITDA
12.3x
P/B
0.7x
Debt/Equity
1.0x
ROE
-2.6%
P/FCF
23.4x
RSI (14)
—
ATR (14)
—
Beta
0.53
50d MA
$21.56
200d MA
$20.58
Avg Volume
741.5K
Edgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care. The Wet Shave segment provides razor systems, such as razor handles and refillable blades, and disposable shave products for men and women under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard, and Personna brands. The Sun and Skin Care segment provides general protection, sport, kids, baby, tanning and after sun products under the Banana Boat and Hawaiian Tropic brands, as well as antibacterial hand wipes, alcohol sanitizing wipes, and hand sanitizer gels under the Wet Ones brand; and skin care products for men under the Bulldog and Jack Black brands, and skin care and grooming products under the Cremo brand. The Feminine Care segment provides tampons under the Playtex Gentle Glide 360°, Playtex Sport, Playtex and o.b. brands; and markets pads and liners under the Stayfree and Carefree brands. The company was formerly known as Energizer Holdings, Inc. and changed its name to Edgewell Personal Care Company in June 2015. Edgewell Personal Care Company was founded in 1772 and is headquartered in Shelton, Connecticut.
6 Research Drive · Shelton, CT 06484 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | TNS | 0.43 | 0.60 | +39.5% | 22.39 | -0.6% | -3.3% | — | — | — | — | — |
| Feb 9, 2026 | TNS | -0.18 | -0.16 | +11.1% | 19.79 | +2.8% | +3.6% | +2.5% | +1.6% | +2.5% | +0.9% | — |
| Nov 13, 2025 | TNS | 0.82 | 0.68 | -17.1% | 18.39 | -2.1% | -1.4% | -1.8% | -5.2% | +3.3% | -2.4% | — |
| Aug 5, 2025 | TNS | 1.01 | 0.92 | -8.9% | 20.29 | +2.5% | +7.0% | +1.8% | -0.4% | +0.0% | +2.2% | — |
| May 7, 2025 | TNS | 0.90 | 0.87 | -3.3% | 27.01 | +0.0% | +0.7% | -0.6% | +6.2% | -1.0% | -1.5% | — |
| Feb 10, 2025 | TNS | 0.13 | 0.07 | -46.2% | 28.60 | +0.3% | -0.0% | +1.5% | +2.4% | +0.2% | +0.5% | — |
| Nov 7, 2024 | TNS | 0.67 | 0.72 | +7.5% | 36.41 | -1.1% | -0.7% | -0.1% | -2.2% | -1.9% | +0.8% | — |
| Aug 6, 2024 | TNS | 1.01 | 1.22 | +20.8% | 38.02 | -0.1% | -1.2% | -0.1% | -0.4% | -2.4% | +1.3% | — |
| May 8, 2024 | TNS | 0.72 | 0.88 | +22.2% | 38.83 | +0.8% | +1.1% | +1.8% | +1.5% | +1.4% | -1.7% | — |
| Feb 7, 2024 | TNS | 0.06 | 0.24 | +300.0% | 38.00 | +1.3% | +3.9% | -0.1% | +1.0% | -2.7% | +0.3% | — |
| Nov 9, 2023 | TNS | 0.64 | 0.72 | +12.5% | 34.48 | +0.8% | -0.8% | -0.3% | +4.5% | +1.3% | -2.1% | — |
| Aug 3, 2023 | TNS | 0.81 | 0.98 | +21.0% | 41.31 | -0.8% | -6.0% | +1.6% | -0.8% | +0.3% | -0.2% | — |
| May 9, 2023 | BMO | 0.35 | 0.56 | +60.0% | 45.47 | +1.5% | -3.4% | +0.9% | -0.2% | -0.6% | +0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $19.79 | $20.35 | +2.8% | +3.6% | +2.5% | +1.6% | +2.5% | +0.9% |
| Feb 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $19.79 | $20.35 | +2.8% | +3.6% | +2.5% | +1.6% | +2.5% | +0.9% |
| Jan 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $16.86 | $16.68 | -1.1% | -0.3% | +2.1% | -1.6% | +4.7% | +2.9% |
| Nov 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $17.80 | $17.41 | -2.2% | -5.2% | +3.3% | -2.4% | +3.0% | -0.4% |
| Nov 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $18.39 | $18.00 | -2.1% | -1.4% | -1.8% | -5.2% | +3.3% | -2.4% |
| Nov 14 | RBC Capital | Maintains | Outperform → Outperform | — | $18.39 | $18.00 | -2.1% | -1.4% | -1.8% | -5.2% | +3.3% | -2.4% |
| Nov 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.39 | $18.00 | -2.1% | -1.4% | -1.8% | -5.2% | +3.3% | -2.4% |
| Sep 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $19.75 | $19.75 | +0.0% | -1.7% | +1.6% | +1.0% | +2.2% | +2.6% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $20.29 | $20.80 | +2.5% | +7.0% | +1.8% | -0.4% | +0.0% | +2.2% |
| Aug 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.29 | $20.80 | +2.5% | +7.0% | +1.8% | -0.4% | +0.0% | +2.2% |
| Aug 6 | Morgan Stanley | Upgrade | Underweight → Equal Weight | — | $20.29 | $20.80 | +2.5% | +7.0% | +1.8% | -0.4% | +0.0% | +2.2% |
| Aug 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.29 | $20.80 | +2.5% | +7.0% | +1.8% | -0.4% | +0.0% | +2.2% |
| Jul 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $26.69 | $26.77 | +0.3% | -4.0% | +0.4% | +0.5% | -1.0% | -0.5% |
| May 8 | RBC Capital | Maintains | Outperform → Outperform | — | $27.01 | $27.01 | +0.0% | +0.7% | -0.6% | +6.2% | -1.0% | -1.5% |
| May 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $27.01 | $27.01 | +0.0% | +0.7% | -0.6% | +6.2% | -1.0% | -1.5% |
| May 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $27.01 | $27.01 | +0.0% | +0.7% | -0.6% | +6.2% | -1.0% | -1.5% |
| May 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $27.01 | $27.01 | +0.0% | +0.7% | -0.6% | +6.2% | -1.0% | -1.5% |
| Apr 17 | UBS | Maintains | Neutral → Neutral | — | $29.22 | $29.24 | +0.1% | +2.8% | -0.1% | +1.4% | -0.5% | +1.2% |
| Apr 11 | Barclays | Maintains | Equal Weight → Equal Weight | — | $29.39 | $29.03 | -1.2% | +1.4% | +0.8% | -1.9% | -0.9% | +2.8% |
| Feb 11 | Barclays | Maintains | Equal Weight → Equal Weight | — | $28.60 | $28.68 | +0.3% | -0.0% | +1.5% | +2.4% | +0.2% | +0.5% |
| Feb 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.60 | $28.68 | +0.3% | -0.0% | +1.5% | +2.4% | +0.2% | +0.5% |
| Feb 11 | Morgan Stanley | Maintains | Underweight → Underweight | — | $28.60 | $28.68 | +0.3% | -0.0% | +1.5% | +2.4% | +0.2% | +0.5% |
| Feb 11 | Canaccord Genuity | Maintains | Buy → Buy | — | $28.60 | $28.68 | +0.3% | -0.0% | +1.5% | +2.4% | +0.2% | +0.5% |
| Feb 11 | RBC Capital | Maintains | Outperform → Outperform | — | $28.60 | $28.68 | +0.3% | -0.0% | +1.5% | +2.4% | +0.2% | +0.5% |
| Jan 17 | Barclays | Maintains | Equal Weight → Equal Weight | — | $33.19 | $33.32 | +0.4% | +1.6% | +0.6% | -1.2% | +1.3% | -0.4% |
| Jan 16 | UBS | Maintains | Neutral → Neutral | — | $32.51 | $32.33 | -0.6% | +2.1% | +1.6% | +0.6% | -1.2% | +1.3% |
| Jan 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $32.12 | $32.03 | -0.3% | -0.2% | +0.6% | -2.2% | +1.3% | +1.3% |
| Nov 11 | Barclays | Maintains | Equal Weight → Equal Weight | — | $36.16 | $36.43 | +0.7% | -0.1% | -2.2% | -1.9% | +0.8% | -0.7% |
| Oct 16 | Truist | Maintains | Buy → Buy | — | $35.48 | $35.37 | -0.3% | +0.9% | +0.3% | -0.4% | -1.3% | -1.8% |
| Oct 11 | Barclays | Maintains | Equal Weight → Equal Weight | — | $34.11 | $34.21 | +0.3% | +2.2% | +0.8% | +1.0% | +0.9% | +0.3% |
| Aug 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $38.02 | $38.00 | -0.1% | -1.2% | -0.1% | -0.4% | -2.4% | +1.3% |
| Aug 7 | UBS | Maintains | Neutral → Neutral | — | $38.02 | $38.00 | -0.1% | -1.2% | -0.1% | -0.4% | -2.4% | +1.3% |
| Jul 19 | Barclays | Maintains | Equal Weight → Equal Weight | — | $40.64 | $40.73 | +0.2% | -0.8% | -0.2% | -1.9% | +1.1% | +0.0% |
| May 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $39.26 | $39.30 | +0.1% | +1.8% | +1.5% | +1.4% | -1.7% | -0.0% |
| May 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $38.83 | $39.15 | +0.8% | +1.1% | +1.8% | +1.5% | +1.4% | -1.7% |
| Apr 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $36.02 | $35.62 | -1.1% | -0.6% | -0.9% | -0.0% | -0.4% | +2.3% |
| Feb 8 | Barclays | Upgrade | Underweight → Equal Weight | — | $38.00 | $38.49 | +1.3% | +3.9% | -0.1% | +1.0% | -2.7% | +0.3% |
| Feb 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $38.00 | $38.49 | +1.3% | +3.9% | -0.1% | +1.0% | -2.7% | +0.3% |
| Jan 16 | Barclays | Maintains | Underweight → Underweight | — | $37.81 | $37.50 | -0.8% | -2.7% | +1.0% | -0.9% | +2.0% | +1.2% |
| Nov 10 | Morgan Stanley | Maintains | Underweight → Underweight | — | $34.48 | $34.74 | +0.8% | -0.8% | -0.3% | +4.5% | +1.3% | -2.1% |
| Oct 12 | Barclays | Maintains | Underweight → Underweight | — | $34.98 | $34.61 | -1.1% | -1.2% | +0.5% | +1.4% | +1.4% | +0.1% |
| Aug 7 | Barclays | Maintains | Underweight → Underweight | — | $38.82 | $38.72 | -0.3% | +1.6% | -0.8% | +0.3% | -0.2% | -0.1% |
| Jul 20 | Barclays | Maintains | Underweight → Underweight | — | $39.41 | $38.63 | -2.0% | -3.7% | +1.4% | +1.9% | +2.1% | -0.6% |
| May 12 | Barclays | Maintains | Underweight → Underweight | — | $44.30 | $44.38 | +0.2% | -0.2% | -0.6% | +0.1% | -0.3% | -1.2% |
| May 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $45.47 | $46.13 | +1.5% | -3.4% | +0.9% | -0.2% | -0.6% | +0.1% |
| May 10 | Morgan Stanley | Maintains | Underweight → Underweight | — | $45.47 | $46.13 | +1.5% | -3.4% | +0.9% | -0.2% | -0.6% | +0.1% |
| Feb 10 | Barclays | Maintains | Underweight → Underweight | — | $44.13 | $43.90 | -0.5% | -0.9% | +1.9% | -1.7% | +1.8% | -1.5% |
| Feb 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $43.59 | $44.71 | +2.6% | +1.2% | -0.9% | +1.9% | -1.7% | +1.8% |
| Nov 14 | Barclays | Maintains | Underweight → Underweight | — | $39.75 | $39.61 | -0.4% | +0.1% | +1.8% | -1.4% | +2.0% | +0.8% |
| Nov 11 | Morgan Stanley | Maintains | Underweight → Underweight | — | $39.96 | $39.98 | +0.1% | -0.5% | +0.1% | +1.8% | -1.4% | +2.0% |
No insider trades available.
8-K · 2.02
!! High
Edgewell Personal Care Company -- 8-K 2.02: Earnings Results
Edgewell Personal Care reported Q2 2026 financial results, indicating the company's operational performance and financial condition for the quarter ending in May 2026.
May 6
8-K · 5.02
!!! Very High
Edgewell Personal Care Company -- 8-K 5.02: Executive Change
Edgewell's executive departure could signal internal instability or strategic disagreement, potentially creating near-term leadership uncertainty that may pressure the stock until a credible successor stabilizes operations and investor confidence.
Feb 9
8-K · 2.01
!!! Very High
Edgewell Personal Care Company -- 8-K 2.01: Acquisition Completed
Edgewell Personal Care completed its acquisition of Essity Aktiebolag, expanding its portfolio in personal care products and strengthening its market position against competitors.
Feb 6
Data updated apr 25, 2026 7:22am
· Source: massive.com